<DOC>
	<DOCNO>NCT01595321</DOCNO>
	<brief_summary>The purpose study estimate safety whole cell vaccine immune modulating dos cyclophosphamide follow SBRT FOLFIRINOX chemotherapy pancreatic cancer patient surgery .</brief_summary>
	<brief_title>Pancreatic Tumor Cell Vaccine ( GVAX ) , Low Dose Cyclophosphamide , Fractionated Stereotactic Body Radiation Therapy ( SBRT ) , FOLFIRINOX Chemotherapy Patients With Resected Adenocarcinoma Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Inclusion Criteria ( abbreviate ) : 1 . Documented cancer pancreas ( head , neck , and/or uncinate process ) , completely resect 2 . No prior Chemotherapy , radiation therapy biologic therapy pancreatic cancer 3 . Must within 10 week surgical resection cancer 4 . Titanium clip ( minimum 1 ) must place time surgery aid SBRT treatment plan 5 . ECOG Performance Status 0 1 6 . Adequate organ function define studyspecified laboratory test 7 . Must use acceptable form birth control study 28 day final dose study drug 8 . Signed informed consent form 9 . Willing able comply study procedure Exclusion criterion ( abbreviate ) : 1 . Currently history certain studyspecified heart , liver , kidney , lung , neurological , immune medical condition 2 . Presence metastatic disease 3 . Clinical metabolic laboratory abnormality define Grade 3 4 National Cancer Institute 's ( NCI 's ) Common Terminology Criteria Adverse Events ( CTCAE ) , version 3.0 4 . Systemically active steroid 5 . Chemotherapy , radiation therapy biologic therapy within 28 day prior receive study drug 6 . Inability begin protocol treatment within 70 day ( 10 week ) surgery remove cancer 7 . History HIV , hepatitis B C infection 8 . Pregnant lactate 9 . Conditions , include alcohol drug dependence , intercurrent illness would affect patient 's ability comply study visit procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Adjuvant therapy</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Cytoxan</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Pancreatic Vaccine</keyword>
	<keyword>Stereotactic radiation therapy</keyword>
	<keyword>SBRT</keyword>
	<keyword>FOLFIRINOX</keyword>
</DOC>